Publications by authors named "John Ieni"

Claim this Profile
E
Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept study.
Ramakrishna Nirogi, John Ieni, Vinod Kumar Goyal, Jyothsna Ravula, Satish Jetta

Alzheimers Dement (N Y)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.
Rachelle S Doody, Jody Corey-Bloom, Richard Zhang, Honglan Li, John Ieni

Drugs Aging· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas.
Johann Meunier, John Ieni, Tangui Maurice

J Pharmacol Exp Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil.
Tangui Maurice, Johann Meunier, Bihua Feng, John Ieni, Daniel T Monaghan

J Pharmacol Exp Ther· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Howard Feldman, Serge Gauthier, Jane Hecker, Bruno Vellas, Yikang Xu, John R Ieni

Int J Geriatr Psychiatry· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.
Ben Seltzer, Parvaneh Zolnouni, Margarita Nunez, Robert Goldman, Dinesh Kumar, John Ieni

Arch Neurol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AD2000: design and conclusions.
Latif Akintade, Michael Zaiac, John R Ieni, Thomas McRae

Lancet· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
K Ranga Rama Krishnan, H Cecil Charles, P Murali Doraiswamy, Jacobo Mintzer, Richard Weisler, John R Ieni

Am J Psychiatry· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.
Larry Tune, Paul J Tiseo, John Ieni, Carlos Perdomo, Raymond D Pratt

Am J Geriatr Psychiatry· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease.
David S Geldmacher, George Provenzano, Thomas McRae, Vera Mastey, John R Ieni

J Am Geriatr Soc· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Studies of the Effect of the Antidepressant Drugs Nefazodone or Paroxetine on [11C]Raclopride Binding in Human Brain.
Joanna S. Fowler, Gene Jack Wang, Nora D. Volkow, John Ieni, Jean Logan

Clin Positron Imaging· July 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis